Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 11/1/12 → 3/31/15 |
Financiación
- Pluristem Therapeutics Incorporated: 8.969,00 US$
Pluristem - A Phase 2, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects with Intermitte
- Saha, Sibu (PI)
- Ferraris, Victor (CoI)
- Minion, David (CoI)
- Sorial, Ehab (CoI)
- Xenos, Eleftherios (CoI)